A prognostic model constructed using the m6A-related genes METTL14 and TYHDF2, whose survival rates for cases in the high-risk group were much lower than those in the low-risk group, can be a potential prognostic biomarker for ES. Here, METTL14 is linked to Ewing sarcoma.